Association of Serum Uric Acid Levels with Leg Ischemia in Patients with Peripheral Arterial Disease After Treatment

Overview

Journal J Atheroscler Thromb

Date 2017 Feb 17

PMID 28202852

Citations 7

Authors

Yoko Sotoda

Shigeki Hirooka

Hiroyuki Orita

Ichiro Wakabayashi

Affiliations

Soon will be listed here.

Abstract

Aim: We investigated the relationships of serum uric acid levels with the progression of atherosclerosis in patients with peripheral arterial disease (PAD) after treatment.

Methods: Subjects were male patients diagnosed with PAD. Atherosclerosis at the common carotid artery was evaluated based on its intima-media thickness (IMT). Leg arterial flow was evaluated by measuring ankle-brachial index (ABI) and exercise-induced decrease in ABI.

Results: Among various risk factors including age, blood pressure, adiposity, estimated glomerular filtration rate, and blood lipid, blood glucose, uric acid, fibrinogen and C-reactive protein levels, only uric acid levels showed significant correlations with ABI [Pearson's correlation coefficient, -0.292 (p＜0.01)] and leg exercise-induced decrease in ABI [Pearson's correlation coefficient, 0.236 (p＜ 0.05)]. However, there was no significant correlation between uric acid levels and maximum or mean IMT. Odds ratios of subjects with the 3rd tertile versus subjects with the 1st tertile for uric acid levels were significantly higher than the reference level of 1.00 for low ABI [4.44 (95% confidence interval, 1.45-13.65, p＜0.01)] and for high % decrease in ABI after exercise [4.31 (95% confidence interval, 1.34-13.82, p＜0.05)]. The associations of uric acid levels with the indicators of leg ischemia were also found after adjustment for age, history of revascularization therapy, diabetes, smoking, alcohol consumption, body mass index, triglyceride levels, and renal function.

Conclusion: Uric acid levels are associated with the degree of leg ischemia in patients with PAD. Further interventional studies are needed to determine whether the correction of uric acid levels is effective in preventing the progression of PAD.

Citing Articles

Hyperuricemia in Cardiac Rehabilitation Patients: Prevalence and Association with Functional Improvement and Left Ventricular Ejection Fraction.

Fortuna M, Tognola C, Algeri M, Shkodra A, Intravaia R, Pezzoli S High Blood Press Cardiovasc Prev. 2024; 31(5):461-471.

PMID: 39107574 PMC: 11485182. DOI: 10.1007/s40292-024-00665-x.

Association between serum uric acid levels and peripheral artery disease in Chinese adults with hypertension.

Han F, Yu C, Hu F, Zhou W, Wang T, Zhu L Front Endocrinol (Lausanne). 2023; 14:1197628.

PMID: 37674616 PMC: 10478083. DOI: 10.3389/fendo.2023.1197628.

Gender Differences in the Association Between Serum Uric Acid and Arteriosclerotic Cardiovascular Risk Among Chinese Type 2 Diabetes Mellitus Patients.

Yang H, Gao J, Li S, Xia H, Chen Z, Zhu S Int J Gen Med. 2021; 14:687-695.

PMID: 33688240 PMC: 7935449. DOI: 10.2147/IJGM.S300196.

Risk factors for peripheral arterial disease in elderly patients with Type-2 diabetes mellitus: A clinical study.

Shou Z, Zhao Y, Zhang Y, Li S Pak J Med Sci. 2020; 36(6):1344-1348.

PMID: 32968406 PMC: 7501018. DOI: 10.12669/pjms.36.6.2906.

miR-214 Protects Against Uric Acid-Induced Endothelial Cell Apoptosis.

Yang B, Li S, Zhu J, Huang S, Zhang A, Jia Z Front Med (Lausanne). 2020; 7:411.

PMID: 32850909 PMC: 7419469. DOI: 10.3389/fmed.2020.00411.

References

Norgren L, Hiatt W, Dormandy J, Nehler M, Harris K, Fowkes F . Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007; 45 Suppl S:S5-67. DOI: 10.1016/j.jvs.2006.12.037. View

Yambe T, Yoshizawa M, Saijo Y, Yamaguchi T, Shibata M, Konno S . Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother. 2005; 58 Suppl 1:S95-8. DOI: 10.1016/s0753-3322(04)80015-5. View

Chen Y, Xu B, Sun W, Sun J, Wang T, Xu Y . Impact of the Serum Uric Acid Level on Subclinical Atherosclerosis in Middle-aged and Elderly Chinese. J Atheroscler Thromb. 2015; 22(8):823-32. DOI: 10.5551/jat.26260. View

Hoyer C, Sandermann J, Petersen L . The toe-brachial index in the diagnosis of peripheral arterial disease. J Vasc Surg. 2013; 58(1):231-8. DOI: 10.1016/j.jvs.2013.03.044. View

Battelli M, Polito L, Bolognesi A . Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress. Atherosclerosis. 2014; 237(2):562-7. DOI: 10.1016/j.atherosclerosis.2014.10.006. View

Mahe G, Pollak A, Liedl D, Cohoon K, Mc Carter C, Rooke T . Discordant Diagnosis of Lower Extremity Peripheral Artery Disease Using American Heart Association Postexercise Guidelines. Medicine (Baltimore). 2015; 94(31):e1277. PMC: 4616614. DOI: 10.1097/MD.0000000000001277. View

Hirsch A, Criqui M, Regensteiner J, Creager M, Olin J, Krook S . Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001; 286(11):1317-24. DOI: 10.1001/jama.286.11.1317. View

Ando K, Takahashi H, Watanabe T, Daidoji H, Otaki Y, Nishiyama S . Impact of Serum Uric Acid Levels on Coronary Plaque Stability Evaluated Using Integrated Backscatter Intravascular Ultrasound in Patients with Coronary Artery Disease. J Atheroscler Thromb. 2016; 23(8):932-9. PMC: 7399302. DOI: 10.5551/jat.33951. View

Borghi C, Agabiti Rosei E, Bardin T, Dawson J, Dominiczak A, Kielstein J . Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015; 33(9):1729-41. DOI: 10.1097/HJH.0000000000000701. View

10.

Tseng C . Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with Type 2 diabetes. Diabet Med. 2004; 21(7):724-9. DOI: 10.1111/j.1464-5491.2004.01239.x. View

11.

Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R . Ultrasonic evaluation of early carotid atherosclerosis. Stroke. 1990; 21(11):1567-72. DOI: 10.1161/01.str.21.11.1567. View

12.

Aboyans V, Criqui M, Abraham P, Allison M, Creager M, Diehm C . Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012; 126(24):2890-909. DOI: 10.1161/CIR.0b013e318276fbcb. View

13.

Haugen S, Casserly I, Regensteiner J, Hiatt W . Risk assessment in the patient with established peripheral arterial disease. Vasc Med. 2007; 12(4):343-50. DOI: 10.1177/1358863X07083278. View

14.

Zhang W, Iso H, Murakami Y, Miura K, Nagai M, Sugiyama D . Serum Uric Acid and Mortality Form Cardiovascular Disease: EPOCH-JAPAN Study. J Atheroscler Thromb. 2016; 23(6):692-703. PMC: 7399280. DOI: 10.5551/jat.31591. View

15.

Robertson A, Struthers A . A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease. Can J Cardiol. 2015; 32(2):190-6. PMC: 4742517. DOI: 10.1016/j.cjca.2015.05.010. View

16.

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33 Suppl 1:S62-9. PMC: 2797383. DOI: 10.2337/dc10-S062. View

17.

Cappola T, Kass D, Nelson G, Berger R, Rosas G, Kobeissi Z . Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation. 2001; 104(20):2407-11. DOI: 10.1161/hc4501.098928. View

18.

Langlois M, De Bacquer D, Duprez D, De Buyzere M, Delanghe J, Blaton V . Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis. 2003; 168(1):163-8. DOI: 10.1016/s0021-9150(03)00093-5. View

19.

Berry C, Hare J . Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol. 2003; 555(Pt 3):589-606. PMC: 1664875. DOI: 10.1113/jphysiol.2003.055913. View

20.

Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H . International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig. 2014; 3(1):39-40. PMC: 4014931. DOI: 10.1111/j.2040-1124.2012.00207.x. View